TY - JOUR
KW - Adult
KW - Buprenorphine/administration & dosage/adverse effects
KW - Comorbidity
KW - Demography
KW - Diagnosis, Dual (Psychiatry)/statistics & numerical data
KW - Female
KW - Humans
KW - Male
KW - Naltrexone/administration & dosage/adverse effects
KW - Narcotic Antagonists/administration & dosage/adverse effects
KW - Opioid-Related Disorders/diagnosis/drug therapy/epidemiology/psychology
KW - Risk-Taking
KW - Sex Factors
AU - A. N. C. Campbell
AU - C. Barbosa-Leiker
AU - M. Hatch-Maillette
AU - S. E. Mennenga
AU - M. Pavlicova
AU - J. Scodes
AU - T. Saraiya
AU - S. G. Mitchell
AU - J. Rotrosen
AU - P. Novo
AU - E. V. Nunes
AU - S. F. Greenfield
A1 - 
BT - The American journal on addictions
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 6
CY - England
DO - 10.1111/ajad.12784
IS - 6
JF - The American journal on addictions
PB - American Academy of Addiction Psychiatry
PP - England
PY - 2018
SN - 1521-0391; 1055-0496
SP - 465
EP - 470
EP - 
T1 - Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial
T2 - The American journal on addictions
TI - Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 30106494
U3 - 10.1111/ajad.12784
VL - 27
VO - 1521-0391; 1055-0496
Y1 - 2018
ER -